Analysis Group

Pair of Digital Health Research Papers Coauthored by Analysis Group Demonstrate Promises of Wearables to Generate Reliable Site-Less Patient-Reported Outcomes in Rheumatoid Arthritis

Retrieved on: 
Tuesday, April 9, 2024
Yee, Aiden, Principal, Observational study, Scientific Reports, Apple, Rheumatoid arthritis, Digital, University, GSK, Bias, Patient, PRO, Research, Nature, Hamy, Analysis Group, Apple Watch, Creagh, Pain, Machine learning, Fatigue

This technology enables clinicians to develop more sensitive and patient-centric endpoints in RA clinical trials and real-world studies.

Key Points: 
  • This technology enables clinicians to develop more sensitive and patient-centric endpoints in RA clinical trials and real-world studies.
  • "Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis," published in February by Nature's npj Digital Medicine (Creagh, A.P., et al.
  • "Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis."
  • "Patient-centric assessment of rheumatoid arthritis using a smartwatch and bespoke mobile app in a clinical setting."

Analysis Group Announces Senior-Level Promotions

Retrieved on: 
Thursday, April 4, 2024
HTA, Consumer, Climate change, Bankruptcy, Algorithm, ERISA, Environment, Agriculture, Data analysis, RWE, Materiality, Biostatistics, Research, History, Policy, Epidemiology, Survival analysis, Insurance, Analysis Group, Advertising, Clinical trial, IP, Ground substance, Intellectual property, Telecommunications, Privacy, Marketing, Economics, Consultant

BOSTON, April 4, 2024 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, announces 32 promotions to vice president across nine offices.

Key Points: 
  • BOSTON, April 4, 2024 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, announces 32 promotions to vice president across nine offices.
  • "We are delighted to announce the largest group of consultant promotions to vice president in the history of our organization," said Martha S. Samuelson, CEO and Chairman of Analysis Group.
  • In Boston, Jonathan E. Baker specializes in the application of economic analysis to antitrust and competition, energy and environment, commercial dispute, class certification, and damages litigation matters.
  • Erica VanSant specializes in economic analysis of complex litigation matters in the areas of health care, antitrust, and IP.

Limb-Girdle Muscular Dystrophy Leaders Advance Collaborative Dialogue to Accelerate Drug Development to Address the Urgent Unmet Need in Limb-Girdle Muscular Dystrophy

Retrieved on: 
Tuesday, February 27, 2024
LGMD, Nationwide Children's Hospital, Analysis Group, OND, FDA, Clinical trial, Food, Drug development, Sarepta Therapeutics, Virginia Commonwealth University, Hospital, Treatment, Senior advisor, Documentation, University, CDER, Therapy, Keynote, Patient, Science, Limb–girdle muscular dystrophy

The meeting focused on six LGMD subtypes: 2A/R1, 2B/R2, 2C/R5, 2D/R3, 2E/R4, and 2I/R9.

Key Points: 
  • The meeting focused on six LGMD subtypes: 2A/R1, 2B/R2, 2C/R5, 2D/R3, 2E/R4, and 2I/R9.
  • We are thrilled that the workshop advanced a collaborative dialogue and brought people together from every facet of the drug development process to drive progress for patients.
  • This was truly a monumental event for the LGMD community and a model for others to follow in the future."
  • In-depth documentation of the workshop's findings and next steps is in progress and will be shared when available.

Vintage Investment Partners Announces Two New Members of Its Strategic Advisory Board

Retrieved on: 
Tuesday, January 30, 2024
Entrepreneurship, Senior, Presidency of Barack Obama, GBS, National Council, Former, Hadassah Medical Center, Research, Ovarian cancer, Hebrew University of Jerusalem, Bank, Genius, CFA, Bank of Israel, University, LLB, Fidelity, Central Waqf Council, Economics, PGD, P&G, Education, Strauss Group, MIT, Berkshire Partners, Analysis Group, SAB, Bank Leumi, GMO, CDPQ, Finance, Harvard University, Doctor of Philosophy, First Nations in Manitoba, Cincinnati metropolitan area, Defense, IBM Consulting, Bed Bath & Beyond, Teaching, Management

Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.

Key Points: 
  • Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.
  • "I am thrilled to have Samer and Andy join our Strategic Advisory Board.
  • More importantly, both bring unique experience and perspectives to Vintage that we are thrilled to tap", said Alan Feld, Founder and Co-Managing Partner of Vintage.
  • The other members of the Vintage SAB include: Bradley Bloom, Former Chairman and Co-Founder of Berkshire Partners, Mark Dubowitz, CEO, Foundation for the Defense of Democracies, Ambassador S. Fitzgerald Haney, Former U.S.

Vishay Intertechnology Appoints John Malvisi to Its Board of Directors

Retrieved on: 
Tuesday, November 28, 2023
Accounting, Analysis Group, Fordham University, Audit committee, Trustee, Catholic Church, MBA, Growth

MALVERN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc., (NYSE: VSH), one of the world's largest manufacturers of discrete semiconductors and passive electronic components, announced the appointment, effective immediately, of Mr. John Malvisi to its Board of Directors and its Audit Committee.

Key Points: 
  • MALVERN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc., (NYSE: VSH), one of the world's largest manufacturers of discrete semiconductors and passive electronic components, announced the appointment, effective immediately, of Mr. John Malvisi to its Board of Directors and its Audit Committee.
  • Mr. Malvisi retired in 2021 as a senior partner in Deloitte & Touche LLP’s audit practice with more than 35 years of client service experience.
  • During his career, Mr. Malvisi has managed several of Deloitte’s largest audit clients in the media & entertainment, and consumer products industries.
  • Mr. Malvisi also served on the Board of Trustees for Catholic Charities of the Archdiocese of New York from 2008 through 2022, including its Audit Committee.

Analysis Group Researchers Evaluated Long-Term Patient Experience with Dupilumab Using Groundbreaking Method for Generating Real-World Data

Retrieved on: 
Tuesday, December 12, 2023
Regeneron Pharmaceuticals, JAMA Dermatology, Analysis Group, Atopic dermatitis, LEAP, Physician, Gold, Pros, Clinical trial, Yale school, RWD, Sinusitis, Harvard Medical School, Polyp (medicine), Yale School of Medicine, Area studies, JAMA, Nursing, Pharmaceutical industry, Sanofi, Dermatology, Patient

The study, published in the journal Dermatology and Therapy , extends the one-year results of the previously published RELIEVE-AD study in JAMA Dermatology , which was based on a groundbreaking method for generating real-world data (RWD).

Key Points: 
  • The study, published in the journal Dermatology and Therapy , extends the one-year results of the previously published RELIEVE-AD study in JAMA Dermatology , which was based on a groundbreaking method for generating real-world data (RWD).
  • This approach provides a true baseline against which to compare longitudinal data over time.
  • "Generating real-world data is particularly challenging for conditions like atopic dermatitis that require long-term therapy extending beyond the initial study period.
  • "Leveraging manufacturers' programs, such as patient support programs, has proven to be a breakthrough solution for generating early and long-term high-quality RWD."

Verdagy Grows Leadership Team and Announces Rahul Bammi as President

Retrieved on: 
Tuesday, October 17, 2023
Climate, MBA, Climate change, Engineering, MS, United States Department of Energy, National Institute of Technology, Tiruchirappalli, University, Stanford University, Arizona State University, National Semiconductor, VCS, Chemical engineering, Marketing, MOSS, Analysis Group, Motorola, KLA, P&L, IPO, Hydrogen, GTM, Silicon, Management, Renewable energy

MOSS LANDING, Calif., Oct. 17, 2023 /PRNewswire/ -- Verdagy, a pioneer in advanced water electrolysis electrolyzer technologies for large-scale industrial applications, today announced the appointment of Rahul Bammi as President. Rahul reports to CEO Marty Neese and will lead Verdagy's revenue, product management and go-to-market functions including sales, origination, business development, product marketing and corporate marketing.

Key Points: 
  • "Rahul is a terrific and exciting addition to the Verdagy leadership team as we continue to build the industry's leading green hydrogen company.
  • His broad experience growing climate and deep tech companies, and introducing leading-edge products will be invaluable as Verdagy commercializes and scales the deployment of its eDynamic® 20-megawatt electrolyzers," said Marty Neese, Verdagy CEO.
  • I'm thrilled to join Verdagy, and look forward to building an enduring company with Marty and the team that makes a meaningful and positive impact on climate change," said Rahul Bammi, Verdagy President.
  • Bammi joins the company at a pivotal time, as Verdagy recently closed a $73-million Series B funding and announced its Silicon Valley factory .

Analysis Group and Stanford University Study Details Impact of California's "Balance Billing" Law on the Cost of Anesthesia Care

Retrieved on: 
Thursday, August 17, 2023
Insurance, Database, Research fellow, Health policy, Stanford School, Stanford University, Economic Policy (journal), Assistant, Analysis Group, Economics, Stanford University School of Medicine, Legislation, Patient, Fellow, Research, Stanford Institute for Economic Policy Research, Stanford Institutes of Medicine Summer Research Program, Biology, Health insurance, Anesthesiology, Anesthesia

The 2017 law's impact on the cost for anesthesiology services provided in network has been contentious, yet has not been fully studied until now.

Key Points: 
  • The 2017 law's impact on the cost for anesthesiology services provided in network has been contentious, yet has not been fully studied until now.
  • The results suggest that the California law's implementation was associated with a statistically significant decline in payments for out-of-network anesthesia care (by 13.6%, or $108 on average) and an increase in payments for in-network anesthesia care (by 3%, or $87 on average).
  • The analysis did not find a statistically significant change in the portion of claims occurring out of network.
  • The study, titled "Association Between 'Balance Billing' Legislation and Anesthesia Payments in California: A Retrospective Analysis," was published in the July issue of Anesthesiology .

Analysis Group Supports Testimony in Pay-for-Delay HIV Treatment Antitrust Matter

Retrieved on: 
Tuesday, August 8, 2023
Efavirenz/emtricitabine/tenofovir, Teva Pharmaceuticals, Teva, HIV, Health, Proskauer Rose, Element, Kirkland & Ellis, Harvard Medical School, Analysis Group, Gilead Sciences, United States district court, District court, Joseph, State, Hospital, Policy, Massachusetts General Hospital, Goodwin, Goodwin Procter, Pharmaceutical industry

BOSTON, Aug. 8, 2023 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, supported academic and medical affiliate Anupam B. Jena in preparing testimony assessing damages and evaluating elements of innovation in developing Gilead Science's HIV treatments.

Key Points: 
  • BOSTON, Aug. 8, 2023 /PRNewswire/ -- Analysis Group , one of the largest international economics consulting firms, supported academic and medical affiliate Anupam B. Jena in preparing testimony assessing damages and evaluating elements of innovation in developing Gilead Science's HIV treatments.
  • Gilead, a Kirkland & Ellis and Proskauer Rose client, was a co-defendant with Teva Pharmaceuticals, a Goodwin Procter client, in a rare pay-for-delay antitrust jury trial.
  • In the matter In re: HIV Antitrust Litigation, health plans and insurers claimed they were overcharged for the Gilead-brand HIV drugs Truvada and Atripla, as well as for the generic versions manufactured by Teva once they became available.
  • An Analysis Group team led by Managing Principal Pavel Darling , Principal Richard Mortimer , and Manager Ngoc Pham assisted Dr. Jena in the preparation of his testimony.

Analysis Group Economists Again Recognized as Top Intellectual Property Experts

Retrieved on: 
Tuesday, July 18, 2023
Analysis Group, Patent, IAM, Knowledge, Intellectual property, Intellectual Asset Management, Research, Consultant, Industrial design

BOSTON, July 18, 2023 /PRNewswire/ -- Fourteen economists from Analysis Group , one of the largest international economics consulting firms, have been recognized as among the top economic experts for intellectual property (IP) matters in this year's IAM Patent 1000 .

Key Points: 
  • BOSTON, July 18, 2023 /PRNewswire/ -- Fourteen economists from Analysis Group , one of the largest international economics consulting firms, have been recognized as among the top economic experts for intellectual property (IP) matters in this year's IAM Patent 1000 .
  • For this annual listing identifying leading patent professionals around the globe, Intellectual Asset Management (IAM) conducts extensive research that includes nearly 2,000 interviews with attorneys.
  • Analysis Group itself was described as "full of exceptional professionals, from the testifying experts to the first-year analysts, the team members hold themselves to a high standard, deliver fantastic work and can handle multiple cases spanning the full range of patent damages issues."
  • To learn more about Analysis Group's capabilities, visit AnalysisGroup.com